Global Precision Genomic Testing Market Overview:
Global Precision Genomic Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Precision Genomic Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Precision Genomic Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Precision Genomic Testing Market:
The Precision Genomic Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Precision Genomic Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Precision Genomic Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Precision Genomic Testing market has been segmented into:
Next-Generation Sequencing
Polymerase Chain Reaction
Microarray Analysis
Sanger Sequencing
By Application, Precision Genomic Testing market has been segmented into:
Oncology
Cardiology
Neurology
Infectious Diseases
Prenatal Testing
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Precision Genomic Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Precision Genomic Testing market.
Top Key Players Covered in Precision Genomic Testing market are:
Thermo Fisher Scientific
Guardant Health
GRAIL
Roche
PerkinElmer
Exact Sciences
BristolMyers Squibb
Abbott Laboratories
Foundation Medicine
Quest Diagnostics
Genomic Health
NantHealth
Illumina
Agilent Technologies
Myriad Genetics
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Precision Genomic Testing Market Type
4.1 Precision Genomic Testing Market Snapshot and Growth Engine
4.2 Precision Genomic Testing Market Overview
4.3 Next-Generation Sequencing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Next-Generation Sequencing: Geographic Segmentation Analysis
4.4 Polymerase Chain Reaction
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Polymerase Chain Reaction: Geographic Segmentation Analysis
4.5 Microarray Analysis
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Microarray Analysis: Geographic Segmentation Analysis
4.6 Sanger Sequencing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Sanger Sequencing: Geographic Segmentation Analysis
Chapter 5: Precision Genomic Testing Market Application
5.1 Precision Genomic Testing Market Snapshot and Growth Engine
5.2 Precision Genomic Testing Market Overview
5.3 Oncology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Oncology: Geographic Segmentation Analysis
5.4 Cardiology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Cardiology: Geographic Segmentation Analysis
5.5 Neurology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Neurology: Geographic Segmentation Analysis
5.6 Infectious Diseases
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Infectious Diseases: Geographic Segmentation Analysis
5.7 Prenatal Testing
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Prenatal Testing: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Precision Genomic Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 GUARDANT HEALTH
6.4 GRAIL
6.5 ROCHE
6.6 PERKINELMER
6.7 EXACT SCIENCES
6.8 BRISTOLMYERS SQUIBB
6.9 ABBOTT LABORATORIES
6.10 FOUNDATION MEDICINE
6.11 QUEST DIAGNOSTICS
6.12 GENOMIC HEALTH
6.13 NANTHEALTH
6.14 ILLUMINA
6.15 AGILENT TECHNOLOGIES
6.16 MYRIAD GENETICS
Chapter 7: Global Precision Genomic Testing Market By Region
7.1 Overview
7.2. North America Precision Genomic Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Next-Generation Sequencing
7.2.2.2 Polymerase Chain Reaction
7.2.2.3 Microarray Analysis
7.2.2.4 Sanger Sequencing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Oncology
7.2.3.2 Cardiology
7.2.3.3 Neurology
7.2.3.4 Infectious Diseases
7.2.3.5 Prenatal Testing
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Precision Genomic Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Next-Generation Sequencing
7.3.2.2 Polymerase Chain Reaction
7.3.2.3 Microarray Analysis
7.3.2.4 Sanger Sequencing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Oncology
7.3.3.2 Cardiology
7.3.3.3 Neurology
7.3.3.4 Infectious Diseases
7.3.3.5 Prenatal Testing
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Precision Genomic Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Next-Generation Sequencing
7.4.2.2 Polymerase Chain Reaction
7.4.2.3 Microarray Analysis
7.4.2.4 Sanger Sequencing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Oncology
7.4.3.2 Cardiology
7.4.3.3 Neurology
7.4.3.4 Infectious Diseases
7.4.3.5 Prenatal Testing
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Precision Genomic Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Next-Generation Sequencing
7.5.2.2 Polymerase Chain Reaction
7.5.2.3 Microarray Analysis
7.5.2.4 Sanger Sequencing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Oncology
7.5.3.2 Cardiology
7.5.3.3 Neurology
7.5.3.4 Infectious Diseases
7.5.3.5 Prenatal Testing
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Precision Genomic Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Next-Generation Sequencing
7.6.2.2 Polymerase Chain Reaction
7.6.2.3 Microarray Analysis
7.6.2.4 Sanger Sequencing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Oncology
7.6.3.2 Cardiology
7.6.3.3 Neurology
7.6.3.4 Infectious Diseases
7.6.3.5 Prenatal Testing
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Precision Genomic Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Next-Generation Sequencing
7.7.2.2 Polymerase Chain Reaction
7.7.2.3 Microarray Analysis
7.7.2.4 Sanger Sequencing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Oncology
7.7.3.2 Cardiology
7.7.3.3 Neurology
7.7.3.4 Infectious Diseases
7.7.3.5 Prenatal Testing
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Precision Genomic Testing Scope:
|
Report Data
|
Precision Genomic Testing Market
|
|
Precision Genomic Testing Market Size in 2025
|
USD XX million
|
|
Precision Genomic Testing CAGR 2025 - 2032
|
XX%
|
|
Precision Genomic Testing Base Year
|
2024
|
|
Precision Genomic Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Guardant Health, GRAIL, Roche, PerkinElmer, Exact Sciences, BristolMyers Squibb, Abbott Laboratories, Foundation Medicine, Quest Diagnostics, Genomic Health, NantHealth, Illumina, Agilent Technologies, Myriad Genetics.
|
|
Key Segments
|
By Type
Next-Generation Sequencing
Polymerase Chain Reaction
Microarray Analysis
Sanger Sequencing
By Applications
Oncology
Cardiology
Neurology
Infectious Diseases
Prenatal Testing
|
